Montreal, Quebec, Canada (PRWEB) June 21, 2010
Sunshine Biopharma, Inc. (OTCBB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has retained investor relations and public relations firm Alchemy Financial Services, Inc. Headquartered in Centennial, CO, Alchemy provides investor relations and public relations services (IR/PR) for publicly traded companies throughout North America.
“We are pleased to have the experience and expertise of the Alchemy team handling our IR/PR function,” said Dr. Steve N. Slilaty, President & CEO of Sunshine Biopharma. “As we move forward with our oncology drug development program we will rely on the Alchemy team to timely and accurately convey our vision, critical business news, and corporate message to our shareholders and the general public.”
“Alchemy is pleased to have Sunshine Biopharma as a valued client. We hope to have a long and mutually beneficial relationship with Sunshine Biopharma in the exciting field of cancer treatment product research and development,” said Craig F. Edwards, President of Alchemy.
About Sunshine Biopharma, Inc.
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company has as its lead compound, Adva-27a (Difluoro-Etoposide™), a multi-purpose anti-tumor compound that is expected to enter Phase I clinical trials in Canada later this year. The Company has licensed this technology on an exclusive basis from Advanomics Corporation, a privately held Canadian company.
About Alchemy Financial Services, Inc.
Alchemy Financial Services is a full service IR/PR firm located in Centennial, CO. The Alchemy team has over 20 years of public relations, investor relations and sales and marketing experience. Alchemy provides publicly traded companies with IR/PR, corporate messaging, business planning and business consulting services.
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
For further information, contact:
Alchemy Financial Services, Inc.